Celltheon
Celltheon Corp: Pioneering cell-engineering tech for human and veterinary pharmaceuticals since 2012.
Founded
2012Celltheon Corp: Pioneering cell-engineering tech for human and veterinary pharmaceuticals since 2012.
Founded in 2012, Celltheon Corporation specializes in cell-engineering technology to advance pharmaceutical preparations for both human and veterinary use. The company's core mission is to provide innovative solutions for the development and manufacturing of complex biologics, addressing significant hurdles in protein expression and manufacturing. Celltheon offers custom cell line development and manufacturing solutions, aiming to accelerate clinical and preclinical development of biologics and challenging antibodies.
Notable figures affiliated with Celltheon include experienced scientists and industry experts who drive its pioneering efforts in biotechnology. The company has secured investments from prominent venture capital firms focused on life sciences. Key achievements include the successful development of proprietary technologies that enhance the efficiency and reliability of biologic production. Overall, Celltheon has made a significant impact by enabling more effective treatments for complex diseases, thereby contributing to advancements in global health.
Companies similar to Celltheon include Cellular Engineering Technologies, Cell BioEngines, Spheringenics and Cellibre.
Celltheon was founded in 2012.
Celltheon's headquarters is located in Union City, CA, US.
Celltheon's most recent funding round was for $200k (USD) in September 2019.
As of Sep 15, 2019, Celltheon has disclosed funding of $200k (USD). Undisclosed round amounts are excluded.
Celltheon has 34 employees as of Feb 5, 2024.
Cellibre
cellibre.com
